The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Interventions for structural heart disease
Treatment of pure aortic insufficiency after aortic stentless valve implantation: increasing safety with a transcatheter inflatable fully repositionable valve
EuroIntervention 2015;11:e1-e2 published online e-article September 2015. DOI: 10.4244/EIJV11I5A117
Stephan Kische, MD, PhD; Giuseppe D’Ancona*, MD, PhD; Jasmin Ortak, MD, PhD; Hüseyin Ince, MD, PhD
Department of Cardiology, Vivantes Klinikum im Friedrichshain Am Urban, Berlin, Germany and Rostock University Medical Center, Rostock, Germany
A 76-year-old patient (logistic EuroSCORE 42.7%) was referred for severe aortic regurgitation (AR) secondary to non-calcific degeneration of a 27 mm stentless prosthesis (Appendix Figure 1). TAVI was performed with a transfemoral inflatable, non-metallic, repositionable and fully retrievable valve (25 mm Direct Flow®; Direct Flow Medical Inc., Santa Rosa, CA, USA) (Figure 1A). With the unsheathed valve in the left ventricle, the rings were inflated at 4 atm (“low pressure technique”). Once the valve was parallel to the aortic valve annulus, the upper ring was deflated. The system’s inner catheter was advanced (black arrow, Figure 1B) in order to shorten the wire’s length ...